{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:06:10Z","timestamp":1791594370877,"version":"4.3.4"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ray Charles Foundation"},{"name":"National Institutes of Health (NIH)\/the National Institute on Aging","award":["R01 AG055865"],"award-info":[{"award-number":["R01 AG055865"]}]},{"name":"National Institutes of Health (NIH)\/the National Institute on Aging","award":["R01 AG055865"],"award-info":[{"award-number":["R01 AG055865"]}]},{"name":"National Institutes of Health (NIH)\/the National Institute on Aging","award":["R01 AG055865"],"award-info":[{"award-number":["R01 AG055865"]}]},{"name":"National Institutes of Health (NIH)\/the National Institute on Aging","award":["R01 AG055865"],"award-info":[{"award-number":["R01 AG055865"]}]},{"name":"National Institutes of Health (NIH)\/the National Institute on Aging","award":["R01 AG055865"],"award-info":[{"award-number":["R01 AG055865"]}]},{"name":"The Hertz Innovation Fund"},{"name":"The Wilstein private foundation"},{"name":"The Saban private foundation"},{"name":"National institutes of Health (NIH)\/the National Institute on Aging","award":["R01AG075998"],"award-info":[{"award-number":["R01AG075998"]}]},{"name":"National institutes of Health (NIH)\/the National Institute on Aging","award":["R01AG075998"],"award-info":[{"award-number":["R01AG075998"]}]},{"name":"National institutes of Health (NIH)\/the National Institute on Aging","award":["R01AG075998"],"award-info":[{"award-number":["R01AG075998"]}]},{"name":"National institutes of Health (NIH)\/the National Institute on Aging","award":["R01AG075998"],"award-info":[{"award-number":["R01AG075998"]}]},{"name":"National institutes of Health (NIH)\/the National Institute on Aging","award":["R01AG075998"],"award-info":[{"award-number":["R01AG075998"]}]},{"name":"Jos\u00e9 Castillejo grants for mobility stays abroad for young doctors 2023","award":["CAS22\/00049"],"award-info":[{"award-number":["CAS22\/00049"]}]},{"name":"Complutense del Amo Grants 2023"},{"name":"The Gordon private foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pathological tau isoforms, including hyperphosphorylated tau at serine 396 (pS396-tau) and tau oligomers (Oligo-tau), are elevated in the retinas of patients with mild cognitive impairment (MCI) due to Alzheimer\u2019s disease (AD) and AD dementia. These patients exhibit significant retinal ganglion cell (RGC) loss, however the presence of tau isoforms in RGCs and their impact on RGC integrity, particularly in early AD, have not been studied. Here, we analyzed retinal superior temporal cross-sections from 25 MCI or AD patients and 16 age- and sex-matched cognitively normal controls. Using the RGC marker ribonucleic acid binding protein with multiple splicing (RBPMS) and Nissl staining, we found a 46\u201356% reduction in RBPMS\n                    <jats:sup>+<\/jats:sup>\n                    RGCs and Nissl\n                    <jats:sup>+<\/jats:sup>\n                    neurons in the ganglion cell layer (GCL) of MCI and AD retinas (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05\u20130.001). RGC loss was accompanied by soma hypertrophy (10\u201350% enlargement,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05\u20130.0001), nuclear displacement, apoptosis (30\u201350% increase,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05\u20130.01), and prominent expression of granulovacuolar degeneration (GVD) bodies and GVD-necroptotic markers. Both pS396-tau and Oligo-tau were identified in RGCs, including in hypertrophic cells. PS396-tau\n                    <jats:sup>+<\/jats:sup>\n                    and Oligo-tau\n                    <jats:sup>+<\/jats:sup>\n                    RGC counts were significantly increased by 2.1\u20133.5-fold in MCI and AD retinas versus control retinas (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05\u20130.0001). Tauopathy-laden RGCs strongly inter-correlated (\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>P<\/jats:italic>\n                    <\/jats:sub>\n                    =0.85,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001) and retinal tauopathy associated with RGC reduction (\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>P<\/jats:italic>\n                    <\/jats:sub>\n                    =-0.40\u2013(-0.64),\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05\u20130.01). Their abundance correlated with brain pathology and cognitive deficits, with higher tauopathy-laden RGCs in patients with Braak stages (V\u2013VI), clinical dementia ratings (CDR\u2009=\u20093), and mini-mental state examination (MMSE \u2264 \u2009\u200926) scores. PS396-tau\n                    <jats:sup>+<\/jats:sup>\n                    RGCs in the central and mid-periphery showed the closest associations with disease status, while Oligo-tau\n                    <jats:sup>+<\/jats:sup>\n                    RGCs in the mid-periphery exhibited the strongest correlations with brain pathology (NFTs, Braak stages, ABC scores;\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>S<\/jats:italic>\n                    <\/jats:sub>\n                    =0.78\u20130.81,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001\u20130.0001) and cognitive decline (MMSE;\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>S<\/jats:italic>\n                    <\/jats:sub>\n                    =-0.79,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.0019). Overall, these findings identify a link between pathogenic tau in RGCs and RGC degeneration in AD, involving apoptotic and GVD-necroptotic cell death pathways. Future research should validate these results in larger and more diverse cohorts and develop RGC tauopathy as a potential noninvasive biomarker for early detection and monitoring of AD progression.\n                  <\/jats:p>","DOI":"10.1186\/s40478-025-01935-y","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:12:09Z","timestamp":1739578329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Miyah R.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Koronyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Salobrar-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altan","family":"Rentsendorj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhakta P.","family":"Gaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo A.","family":"Sadun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Ljubimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Hawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieu-Trang","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Koronyo-Hamaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"1935_CR1","doi-asserted-by":"publisher","unstructured":"(2024) 2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 20: 3708\u20133821 https:\/\/doi.org\/10.1002\/alz.13809","DOI":"10.1002\/alz.13809"},{"key":"1935_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/WNR.0b013e3283497334","volume":"22","author":"PN Alexandrov","year":"2011","unstructured":"Alexandrov PN, Pogue A, Bhattacharjee S, Lukiw WJ (2011) Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer\u2019s disease. NeuroReport 22(12):623\u2013627. https:\/\/doi.org\/10.1097\/WNR.0b013e3283497334","journal-title":"NeuroReport"},{"key":"1935_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40478-015-0187-1","volume":"3","author":"T Arendt","year":"2015","unstructured":"Arendt T, Bruckner MK, Morawski M, Jager C, Gertz HJ (2015) Early neurone loss in Alzheimer\u2019s disease: cortical or subcortical? Acta Neuropathol Commun 3:10. https:\/\/doi.org\/10.1186\/s40478-015-0187-1","journal-title":"Acta Neuropathol Commun"},{"key":"1935_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/opo.12220","volume":"35","author":"R Armstrong","year":"2015","unstructured":"Armstrong R, Kergoat H (2015) Oculo-visual changes and clinical considerations affecting older patients with dementia. Ophthalmic Physiol Opt 35(4):352\u2013376. https:\/\/doi.org\/10.1111\/opo.12220","journal-title":"Ophthalmic Physiol Opt"},{"key":"1935_CR5","doi-asserted-by":"publisher","first-page":"e0232785","DOI":"10.1371\/journal.pone.0232785","volume":"15","author":"S Asanad","year":"2020","unstructured":"Asanad S, Fantini M, Sultan W, Nassisi M, Felix CM, Wu J, Karanjia R, Ross-Cisneros FN, Sagare AP, Zlokovic BV et al (2020) Retinal nerve fiber layer thickness predicts CSF amyloid\/tau before cognitive decline. PLoS ONE 15:e0232785. https:\/\/doi.org\/10.1371\/journal.pone.0232785","journal-title":"PLoS ONE"},{"key":"1935_CR6","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1038\/s41598-021-85010-1","volume":"11","author":"S Asanad","year":"2021","unstructured":"Asanad S, Felix CM, Fantini M, Harrington MG, Sadun AA, Karanjia R (2021) Retinal ganglion cell dysfunction in preclinical Alzheimer\u2019s disease: an electrophysiologic biomarker signature. Sci Rep 11:6344. https:\/\/doi.org\/10.1038\/s41598-021-85010-1","journal-title":"Sci Rep"},{"key":"1935_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1167\/iovs.18-25966","volume":"60","author":"S Asanad","year":"2019","unstructured":"Asanad S, Ross-Cisneros FN, Nassisi M, Barron E, Karanjia R, Sadun AA (2019) The retina in Alzheimer\u2019s Disease: histomorphometric analysis of an ophthalmologic biomarker. Invest Ophthalmol Vis Sci 60:1491\u20131500. https:\/\/doi.org\/10.1167\/iovs.18-25966","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1935_CR8","doi-asserted-by":"publisher","unstructured":"Ashraf G, McGuinness M, Khan MA, Obtinalla C, Hadoux X, van Wijngaarden P (2023) Retinal imaging biomarkers of Alzheimer\u2019s disease: a systematic review and meta-analysis of studies using brain amyloid beta status for case definition. Alzheimers Dement (Amst) 15(2):e12421. https:\/\/doi.org\/10.1002\/dad2.12421","DOI":"10.1002\/dad2.12421"},{"key":"1935_CR9","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awv024","volume":"138","author":"A Baker-Nigh","year":"2015","unstructured":"Baker-Nigh A, Vahedi S, Davis EG, Weintraub S, Bigio EH, Klein WL, Geula C (2015) Neuronal amyloid-beta accumulation within cholinergic basal forebrain in ageing and Alzheimer\u2019s disease. Brain 138(6):1722\u20131737. https:\/\/doi.org\/10.1093\/brain\/awv024","journal-title":"Brain"},{"key":"1935_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/eye.2015.154","volume":"29","author":"SI Balendra","year":"2015","unstructured":"Balendra SI, Normando EM, Bloom PA, Cordeiro MF (2015) Advances in retinal ganglion cell imaging. Eye (Lond) 29:1260\u20131269. https:\/\/doi.org\/10.1038\/eye.2015.154","journal-title":"Eye (Lond)"},{"key":"1935_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00401-024-02747-5","volume":"147","author":"S Balusu","year":"2024","unstructured":"Balusu S, De Strooper B (2024) The necroptosis cell death pathway drives neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol 147:96. https:\/\/doi.org\/10.1007\/s00401-024-02747-5","journal-title":"Acta Neuropathol"},{"key":"1935_CR12","doi-asserted-by":"publisher","unstructured":"Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, Jicha G, Carlsson C, Burns J, Quinn J et al (2018) Version 3 of the national alzheimer\u2019s coordinating center\u2019s uniform data set. Alzheimer Dis Assoc Disord 32(4):351\u2013358. https:\/\/doi.org\/10.1097\/WAD.0000000000000279","DOI":"10.1097\/WAD.0000000000000279"},{"key":"1935_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40478-020-01094-2","volume":"8","author":"RJ Bevan","year":"2020","unstructured":"Bevan RJ, Hughes TR, Williams PA, Good MA, Morgan BP, Morgan JE (2020) Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer\u2019s disease. Acta Neuropathol Commun 8(1):216. https:\/\/doi.org\/10.1186\/s40478-020-01094-2","journal-title":"Acta Neuropathol Commun"},{"key":"1935_CR14","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1172\/JCI69003","volume":"123","author":"LJ Blair","year":"2013","unstructured":"Blair LJ, Nordhues BA, Hill SE, Scaglione KM, O\u2019Leary JC 3rd, Fontaine SN, Breydo L, Zhang B, Li P, Wang L et al (2013) Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. J Clin Invest 123(10):4158\u20134169. https:\/\/doi.org\/10.1172\/JCI69003","journal-title":"J Clin Invest"},{"key":"1935_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/0006-8993(89)90653-7","volume":"501","author":"JC Blanks","year":"1989","unstructured":"Blanks JC, Hinton DR, Sadun AA, Miller CA (1989) Retinal ganglion cell degeneration in Alzheimer\u2019s disease. Brain Res 501:364\u2013372. https:\/\/doi.org\/10.1016\/0006-8993(89)90653-7","journal-title":"Brain Res"},{"key":"1935_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","volume":"17","author":"JC Blanks","year":"1996","unstructured":"Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer\u2019s disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17(3):385\u2013395. https:\/\/doi.org\/10.1016\/0197-4580(96)00009-7","journal-title":"Neurobiol Aging"},{"key":"1935_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0197-4580(96)00010-3","volume":"17","author":"JC Blanks","year":"1996","unstructured":"Blanks JC, Torigoe Y, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer\u2019s disease. I. Ganglion cell loss in foveal\/parafoveal retina. Neurobiol Aging 17(3):377\u2013384. https:\/\/doi.org\/10.1016\/0197-4580(96)00010-3","journal-title":"Neurobiol Aging"},{"key":"1935_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71(4):505\u2013508. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847","journal-title":"JAMA Neurol"},{"key":"1935_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4):389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"key":"1935_CR20","doi-asserted-by":"publisher","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J et al (2016) Tau and Abeta imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med 8:338ra66. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2362","DOI":"10.1126\/scitranslmed.aaf2362"},{"key":"1935_CR21","doi-asserted-by":"publisher","unstructured":"Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, Readhead B, Dudley JT, Spangenberg EE, Green KN et al (2017) Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci 20(9):1236\u20131246. https:\/\/doi.org\/10.1038\/nn.4608","DOI":"10.1038\/nn.4608"},{"key":"1935_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.10.7.5","volume":"10","author":"KJ Cao","year":"2021","unstructured":"Cao KJ, Kim JH, Kroeger H, Gaffney PM, Lin JH, Sigurdson CJ, Yang J (2021) ARCAM-1 facilitates fluorescence detection of amyloid-containing deposits in the Retina. Transl Vis Sci Technol 10(7):5. https:\/\/doi.org\/10.1167\/tvst.10.7.5","journal-title":"Transl Vis Sci Technol"},{"key":"1935_CR23","doi-asserted-by":"publisher","first-page":"1232941","DOI":"10.3389\/fnagi.2023.1232941","volume":"15","author":"S Chen","year":"2023","unstructured":"Chen S, Zhang D, Zheng H, Cao T, Xia K, Su M, Meng Q (2023) The association between retina thinning and hippocampal atrophy in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review. Front Aging Neurosci 15:1232941. https:\/\/doi.org\/10.3389\/fnagi.2023.1232941","journal-title":"Front Aging Neurosci"},{"key":"1935_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-017-0199-3","volume":"12","author":"M Chiasseu","year":"2017","unstructured":"Chiasseu M, Alarcon-Martinez L, Belforte N, Quintero H, Dotigny F, Destroismaisons L, Vande Velde C, Panayi F, Louis C, Di Polo A (2017) Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener 12(1):58. https:\/\/doi.org\/10.1186\/s13024-017-0199-3","journal-title":"Mol Neurodegener"},{"key":"1935_CR25","doi-asserted-by":"publisher","unstructured":"Colom-Cadena M, Davies C, Sirisi S, Lee JE, Simzer EM, Tzioras M, Querol-Vilaseca M, Sanchez-Aced E, Chang YY, Holt K et al (2023) Synaptic oligomeric tau in Alzheimer\u2019s disease - A potential culprit in the spread of tau pathology through the brain. Neuron 111(14):2170\u20132183.e6. https:\/\/doi.org\/10.1016\/j.neuron.2023.04.020","DOI":"10.1016\/j.neuron.2023.04.020"},{"key":"1935_CR26","doi-asserted-by":"publisher","first-page":"e0134750","DOI":"10.1371\/journal.pone.0134750","volume":"10","author":"G Coppola","year":"2015","unstructured":"Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, Barboni P, Pierelli F, Sadun AA, Parisi V (2015) Optical coherence tomography in Alzheimer\u2019s Disease: a Meta-analysis. PLoS ONE 10(8):e0134750. https:\/\/doi.org\/10.1371\/journal.pone.0134750","journal-title":"PLoS ONE"},{"key":"1935_CR27","doi-asserted-by":"publisher","first-page":"100976","DOI":"10.1016\/j.preteyeres.2021.100976","volume":"86","author":"MF Cordeiro","year":"2022","unstructured":"Cordeiro MF, Hill D, Patel R, Corazza P, Maddison J, Younis S (2022) Detecting retinal cell stress and apoptosis with DARC: progression from lab to clinic. Prog Retin Eye Res 86:100976. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100976","journal-title":"Prog Retin Eye Res"},{"key":"1935_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","volume":"6","author":"J den Haan","year":"2018","unstructured":"den Haan J, Morrema THJ, Verbraak FD, de Boer JF, Scheltens P, Rozemuller AJ, Bergen AAB, Bouwman FH, Hoozemans JJ (2018) Amyloid-beta and phosphorylated tau in post-mortem Alzheimer\u2019s disease retinas. Acta Neuropathol Commun 6(1):147. https:\/\/doi.org\/10.1186\/s40478-018-0650-x","journal-title":"Acta Neuropathol Commun"},{"key":"1935_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-022-02567-y","volume":"19","author":"Y Dong","year":"2022","unstructured":"Dong Y, Yu H, Li X, Bian K, Zheng Y, Dai M, Feng X, Sun Y, He Y, Yu B et al (2022) Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer\u2019s disease. J Neuroinflammation 19:205. https:\/\/doi.org\/10.1186\/s12974-022-02567-y","journal-title":"J Neuroinflammation"},{"key":"1935_CR30","doi-asserted-by":"publisher","first-page":"pgac164","DOI":"10.1093\/pnasnexus\/pgac164","volume":"1","author":"X Du","year":"2022","unstructured":"Du X, Koronyo Y, Mirzaei N, Yang C, Fuchs DT, Black KL, Koronyo-Hamaoui M, Gao L (2022) Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid beta-protein and phosphorylated tau. PNAS Nexus 1(4):pgac164. https:\/\/doi.org\/10.1093\/pnasnexus\/pgac164","journal-title":"PNAS Nexus"},{"key":"1935_CR31","doi-asserted-by":"publisher","unstructured":"Dumitrascu OM, Lyden PD, Torbati T, Sheyn J, Sherzai A, Sherzai D, Sherman DS, Rosenberry R, Cheng S, Johnson KO et al (2020) Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline. Alzheimers Dement (Amst) 12(1):e12109. https:\/\/doi.org\/10.1002\/dad2.12109","DOI":"10.1002\/dad2.12109"},{"key":"1935_CR32","doi-asserted-by":"publisher","unstructured":"Dumitrascu OM, Rosenberry R, Sherman DS, Khansari MM, Sheyn J, Torbati T, Sherzai A, Sherzai D, Johnson KO, Czeszynski AD et al (2021) Retinal Venular Tortuosity jointly with retinal amyloid Burden correlates with Verbal Memory loss: a pilot study. Cells 10(11):2926. https:\/\/doi.org\/10.3390\/cells10112926","DOI":"10.3390\/cells10112926"},{"key":"1935_CR33","doi-asserted-by":"publisher","unstructured":"Elvira-Hurtado L, Lopez-Cuenca I, de Hoz R, Salas M, Sanchez-Puebla L, Ramirez-Torano F, Matamoros JA, Fernandez-Albarral JA, Rojas P Alfonsin S (2023) Alzheimer\u2019s disease: a continuum with visual involvements. Front Psychol 14: 1124830 https:\/\/doi.org\/10.3389\/fpsyg.2023.1124830","DOI":"10.3389\/fpsyg.2023.1124830"},{"key":"1935_CR34","doi-asserted-by":"publisher","unstructured":"Erskine L, Herrera E (2014) Connecting the retina to the brain. ASN Neuro 6(6):1759091414562107. https:\/\/doi.org\/10.1177\/1759091414562107","DOI":"10.1177\/1759091414562107"},{"key":"1935_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"1935_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF02150634","volume":"222","author":"L Frisen","year":"1984","unstructured":"Frisen L, Quigley HA (1984) Visual acuity in optic atrophy: a quantitative clinicopathological analysis. Graefes Arch Clin Exp Ophthalmol 222:71\u201374. https:\/\/doi.org\/10.1007\/BF02150634","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1935_CR37","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1038\/s41467-022-32592-7","volume":"13","author":"L Frontzkowski","year":"2022","unstructured":"Frontzkowski L, Ewers M, Brendel M, Biel D, Ossenkoppele R, Hager P, Steward A, Dewenter A, Romer S, Rubinski A et al (2022) Earlier Alzheimer\u2019s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading. Nat Commun 13:4899. https:\/\/doi.org\/10.1038\/s41467-022-32592-7","journal-title":"Nat Commun"},{"key":"1935_CR38","doi-asserted-by":"publisher","unstructured":"Gaire BP, Koronyo Y, Fuchs D-T, Shi H, Rentsendorj A, Danziger R, Vit J-PS, Mirzaei N, Doustar J, Sheyn J et al (2024) Alzheimer\u2019s disease pathophysiology in the retina. Prog Retinal Eye Res 101:101273. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101273","DOI":"10.1016\/j.preteyeres.2024.101273"},{"key":"1935_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ana.10680","volume":"54","author":"MC Gastard","year":"2003","unstructured":"Gastard MC, Troncoso JC, Koliatsos VE (2003) Caspase activation in the limbic cortex of subjects with early Alzheimer\u2019s disease. Ann Neurol 54(3):393\u2013398. https:\/\/doi.org\/10.1002\/ana.10680","journal-title":"Ann Neurol"},{"key":"1935_CR40","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fnins.2019.00925","volume":"13","author":"A Grimaldi","year":"2019","unstructured":"Grimaldi A, Pediconi N, Oieni F, Pizzarelli R, Rosito M, Giubettini M, Santini T, Limatola C, Ruocco G, Ragozzino D et al (2019) Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of Alzheimer\u2019s disease patients, possible biomarkers for early diagnosis. Front Neurosci 13:925. https:\/\/doi.org\/10.3389\/fnins.2019.00925","journal-title":"Front Neurosci"},{"key":"1935_CR41","doi-asserted-by":"publisher","unstructured":"Groot C, Smith R, Stomrud E, Binette AP, Leuzy A, Wuestefeld A, Wisse LEM, Palmqvist S, Mattsson-Carlgren N Janelidze S (2023) phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals. Brain 146(4):1580\u20131591. https:\/\/doi.org\/10.1093\/brain\/awac329","DOI":"10.1093\/brain\/awac329"},{"key":"1935_CR42","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913\u20134917. https:\/\/doi.org\/10.1073\/pnas.83.13.4913","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1935_CR43","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1038\/s41467-019-12242-1","volume":"10","author":"X Hadoux","year":"2019","unstructured":"Hadoux X, Hui F, Lim JKH, Masters CL, Pebay A, Chevalier S, Ha J, Loi S, Fowler CJ, Rowe C et al (2019) Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease. Nat Commun 10:4227. https:\/\/doi.org\/10.1038\/s41467-019-12242-1","journal-title":"Nat Commun"},{"key":"1935_CR44","doi-asserted-by":"publisher","first-page":"30661","DOI":"10.1073\/pnas.2010943117","volume":"117","author":"DX Hammer","year":"2020","unstructured":"Hammer DX, Agrawal A, Villanueva R, Saeedi O, Liu Z (2020) Label-free adaptive optics imaging of human retinal macrophage distribution and dynamics. Proc Natl Acad Sci USA 117(48):30661\u201330669. https:\/\/doi.org\/10.1073\/pnas.2010943117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1935_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00401-024-02769-z","volume":"148","author":"FJ Hart de Ruyter","year":"2024","unstructured":"Hart de Ruyter FJ, Evers M, Morrema THJ, Dijkstra AA, den Haan J, Twisk JWR, de Boer JF, Scheltens P, Bouwman FH, Verbraak FD et al (2024) Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases. Acta Neuropathol 148(1):24. https:\/\/doi.org\/10.1007\/s00401-024-02769-z","journal-title":"Acta Neuropathol"},{"key":"1935_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02525-1","author":"FJ Hart de Ruyter","year":"2022","unstructured":"Hart de Ruyter FJ, Morrema THJ, den Haan J, Netherlands Brain B, Twisk JWR, de Boer JF, Scheltens P, Boon BDC, Thal DR, Rozemuller AJ et al (2022) Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer\u2019s disease and primary tauopathies. Acta Neuropathol 145(2):197\u2013218. https:\/\/doi.org\/10.1007\/s00401-022-02525-1","journal-title":"Acta Neuropathol"},{"key":"1935_CR47","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","volume":"132","author":"NJ Hart","year":"2016","unstructured":"Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M (2016) Ocular indicators of Alzheimer\u2019s: exploring disease in the retina. Acta Neuropathol 132(6):767\u2013787. https:\/\/doi.org\/10.1007\/s00401-016-1613-6","journal-title":"Acta Neuropathol"},{"key":"1935_CR48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic-nerve degeneration in Alzheimer\u2019s disease. N Engl J Med 315:485\u2013487. https:\/\/doi.org\/10.1056\/NEJM198608213150804","journal-title":"N Engl J Med"},{"key":"1935_CR49","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2353\/ajpath.2009.080814","volume":"174","author":"JJ Hoozemans","year":"2009","unstructured":"Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W (2009) The unfolded protein response is activated in pretangle neurons in Alzheimer\u2019s disease hippocampus. Am J Pathol 174:1241\u20131251. https:\/\/doi.org\/10.2353\/ajpath.2009.080814","journal-title":"Am J Pathol"},{"key":"1935_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimers Dement"},{"key":"1935_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0006-8993(74)90798-7","volume":"77","author":"K Iqbal","year":"1974","unstructured":"Iqbal K, Wisniewski HM, Shelanski ML, Brostoff S, Liwnicz BH, Terry RD (1974) Protein changes in senile dementia. Brain Res 77:337\u2013343. https:\/\/doi.org\/10.1016\/0006-8993(74)90798-7","journal-title":"Brain Res"},{"key":"1935_CR52","doi-asserted-by":"publisher","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J et al (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562 https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"1935_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jneumeth.2009.07.010","volume":"184","author":"A Kadar","year":"2009","unstructured":"Kadar A, Wittmann G, Liposits Z, Fekete C (2009) Improved method for combination of immunocytochemistry and nissl staining. J Neurosci Methods 184:115\u2013118. https:\/\/doi.org\/10.1016\/j.jneumeth.2009.07.010","journal-title":"J Neurosci Methods"},{"key":"1935_CR54","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.410260207","volume":"26","author":"B Katz","year":"1989","unstructured":"Katz B, Rimmer S, Iragui V, Katzman R (1989) Abnormal pattern electroretinogram in Alzheimer\u2019s disease: evidence for retinal ganglion cell degeneration? Ann Neurol 26:221\u2013225. https:\/\/doi.org\/10.1002\/ana.410260207","journal-title":"Ann Neurol"},{"key":"1935_CR55","doi-asserted-by":"publisher","first-page":"19440","DOI":"10.1074\/jbc.M112.346072","volume":"287","author":"N Kfoury","year":"2012","unstructured":"Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI (2012) Trans-cellular propagation of tau aggregation by fibrillar species. J Biol Chem 287:19440\u201319451. https:\/\/doi.org\/10.1074\/jbc.M112.346072","journal-title":"J Biol Chem"},{"key":"1935_CR56","doi-asserted-by":"publisher","first-page":"661938","DOI":"10.3389\/fneur.2021.661938","volume":"12","author":"US Kim","year":"2021","unstructured":"Kim US, Mahroo OA, Mollon JD, Yu-Wai-Man P (2021) Retinal ganglion cells-diversity of cell types and clinical relevance. Front Neurol 12:661938. https:\/\/doi.org\/10.3389\/fneur.2021.661938","journal-title":"Front Neurol"},{"key":"1935_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e318267fd5f","volume":"33","author":"S Kirbas","year":"2013","unstructured":"Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33:58\u201361. https:\/\/doi.org\/10.1097\/WNO.0b013e318267fd5f","journal-title":"J Neuroophthalmol"},{"key":"1935_CR58","first-page":"1044","volume":"39","author":"T Kivela","year":"1998","unstructured":"Kivela T (1998) Parvalbumin, a horizontal cell-associated calcium-binding protein in retinoblastoma eyes. Invest Ophthalmol Vis Sci 39:1044\u20131048","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1935_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2478\/s13380-012-0032-y","volume":"3","author":"KJ Kopeikina","year":"2012","unstructured":"Kopeikina KJ, Hyman BT, Spires-Jones TL (2012) Soluble forms of tau are toxic in Alzheimer\u2019s disease. Transl Neurosci 3:223\u2013233. https:\/\/doi.org\/10.2478\/s13380-012-0032-y","journal-title":"Transl Neurosci"},{"key":"1935_CR60","doi-asserted-by":"publisher","first-page":"eadf5128","DOI":"10.1126\/scitranslmed.adf5128","volume":"16","author":"MJ Koper","year":"2024","unstructured":"Koper MJ, Moonen S, Ronisz A, Ospitalieri S, Callaerts-Vegh Z, T\u2019Syen D, Rabe S, Staufenbiel M, De Strooper B, Balusu S et al (2024) Inhibition of an Alzheimer\u2019s disease-associated form of necroptosis rescues neuronal death in mouse models. Sci Transl Med 16:eadf5128. https:\/\/doi.org\/10.1126\/scitranslmed.adf5128","journal-title":"Sci Transl Med"},{"key":"1935_CR61","doi-asserted-by":"publisher","unstructured":"Koper MJ, Tome SO, Gawor K, Belet A, Van Schoor E, Schaeverbeke J, Vandenberghe R, Vandenbulcke M, Ghebremedhin E Otto M (2022) LATE-NC aggravates GVD-mediated necroptosis in Alzheimer\u2019s disease. Acta Neuropathol Commun 10:128. https:\/\/doi.org\/10.1186\/s40478-022-01432-6","DOI":"10.1186\/s40478-022-01432-6"},{"key":"1935_CR62","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-019-02103-y","volume":"139","author":"MJ Koper","year":"2020","unstructured":"Koper MJ, Van Schoor E, Ospitalieri S, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Tousseyn T, Balusu S, De Strooper B, Thal DR (2020) Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer\u2019s disease. Acta Neuropathol 139:463\u2013484. https:\/\/doi.org\/10.1007\/s00401-019-02103-y","journal-title":"Acta Neuropathol"},{"key":"1935_CR63","doi-asserted-by":"publisher","unstructured":"Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ, Kile SJ, Blanco A, Fuchs DT, Ashfaq A et al (2017) Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight 2(16):e93621. https:\/\/doi.org\/10.1172\/jci.insight.93621","DOI":"10.1172\/jci.insight.93621"},{"key":"1935_CR64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","volume":"145","author":"Y Koronyo","year":"2023","unstructured":"Koronyo Y, Rentsendorj A, Mirzaei N, Regis GC, Sheyn J, Shi H, Barron E, Cook-Wiens G, Rodriguez AR, Medeiros R et al (2023) Retinal pathological features and proteome signatures of Alzheimer\u2019s disease. Acta Neuropathol 145(4):409\u2013438. https:\/\/doi.org\/10.1007\/s00401-023-02548-2","journal-title":"Acta Neuropathol"},{"issue":"Suppl 1","key":"1935_CR65","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL (2011) Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. NeuroImage 54(Suppl 1):S204\u2013217. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020","journal-title":"NeuroImage"},{"key":"1935_CR66","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1167\/iovs.09-4098","volume":"51","author":"JM Kwong","year":"2010","unstructured":"Kwong JM, Caprioli J, Piri N (2010) RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. Invest Ophthalmol Vis Sci 51:1052\u20131058. https:\/\/doi.org\/10.1167\/iovs.09-4098","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1935_CR67","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1038\/s41467-023-39328-1","volume":"14","author":"N Kyalu Ngoie Zola","year":"2023","unstructured":"Kyalu Ngoie Zola N, Balty C, Pyr Dit Ruys S, Vanparys AAT, Huyghe NDG, Herinckx G, Johanns M, Boyer E, Kienlen-Campard P, Rider MH al (2023) Specific post-translational modifications of soluble tau protein distinguishes Alzheimer\u2019s disease and primary tauopathies. Nat Commun 14:3706. https:\/\/doi.org\/10.1038\/s41467-023-39328-1","journal-title":"Nat Commun"},{"key":"1935_CR68","doi-asserted-by":"publisher","unstructured":"La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M et al (2020) Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med 12(524):eaau5732. https:\/\/doi.org\/10.1126\/scitranslmed.aau5732","DOI":"10.1126\/scitranslmed.aau5732"},{"key":"1935_CR69","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fneur.2017.00710","volume":"8","author":"C La Morgia","year":"2017","unstructured":"La Morgia C, Di Vito L, Carelli V, Carbonelli M (2017) Patterns of retinal ganglion cell damage in neurodegenerative disorders: parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography studies. Front Neurol 8:710. https:\/\/doi.org\/10.3389\/fneur.2017.00710","journal-title":"Front Neurol"},{"key":"1935_CR70","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, Sambati L, Pan BX, Tozer KR, Barboni P et al (2016) Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol 79:90\u2013109. https:\/\/doi.org\/10.1002\/ana.24548","journal-title":"Ann Neurol"},{"key":"1935_CR71","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95:6448\u20136453. https:\/\/doi.org\/10.1073\/pnas.95.11.6448","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1935_CR72","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.neubiorev.2006.10.003","volume":"31","author":"R Laycock","year":"2007","unstructured":"Laycock R, Crewther SG, Crewther DP (2007) A role for the \u2018magnocellular advantage\u2019 in visual impairments in neurodevelopmental and psychiatric disorders. Neurosci Biobehav Rev 31:363\u2013376. https:\/\/doi.org\/10.1016\/j.neubiorev.2006.10.003","journal-title":"Neurosci Biobehav Rev"},{"key":"1935_CR73","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fnins.2020.00758","volume":"14","author":"S Lee","year":"2020","unstructured":"Lee S, Jiang K, McIlmoyle B, To E, Xu QA, Hirsch-Reinshagen V, Mackenzie IR, Hsiung GR, Eadie BD, Sarunic MV et al (2020) Amyloid Beta immunoreactivity in the retinal ganglion cell layer of the Alzheimer\u2019s Eye. Front Neurosci 14:758. https:\/\/doi.org\/10.3389\/fnins.2020.00758","journal-title":"Front Neurosci"},{"key":"1935_CR74","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13195-020-00715-1","volume":"12","author":"S Lemmens","year":"2020","unstructured":"Lemmens S, Van Craenendonck T, Van Eijgen J, De Groef L, Bruffaerts R, de Jesus DA, Charle W, Jayapala M, Sunaric-Megevand G, Standaert A et al (2020) Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer\u2019s disease patients. Alzheimers Res Ther 12:144. https:\/\/doi.org\/10.1186\/s13195-020-00715-1","journal-title":"Alzheimers Res Ther"},{"key":"1935_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-023-01166-0","volume":"15","author":"I Lopez-Cuenca","year":"2023","unstructured":"Lopez-Cuenca I, Nebreda A, Garcia-Colomo A, Salobrar-Garcia E, de Frutos-Lucas J, Bruna R, Ramirez AI, Ramirez-Torano F, Salazar JJ, Barabash A et al (2023) Early visual alterations in individuals at-risk of Alzheimer\u2019s disease: a multidisciplinary approach. Alzheimers Res Ther 15:19. https:\/\/doi.org\/10.1186\/s13195-023-01166-0","journal-title":"Alzheimers Res Ther"},{"key":"1935_CR76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-022-00998-6","volume":"14","author":"A Lopez-de-Eguileta","year":"2022","unstructured":"Lopez-de-Eguileta A, Lopez-Garcia S, Lage C, Pozueta A, Garcia-Martinez M, Kazimierczak M, Bravo M, Irure J, Lopez-Hoyos M, Munoz-Cacho P et al (2022) The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals. Alzheimers Res Ther 14:57. https:\/\/doi.org\/10.1186\/s13195-022-00998-6","journal-title":"Alzheimers Res Ther"},{"key":"1935_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2010.06.006","volume":"480","author":"Y Lu","year":"2010","unstructured":"Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, Ma D (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer\u2019s disease: evidence in optical coherence tomography. Neurosci Lett 480:69\u201372. https:\/\/doi.org\/10.1016\/j.neulet.2010.06.006","journal-title":"Neurosci Lett"},{"key":"1935_CR78","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1167\/iovs.13-12046","volume":"54","author":"E Marziani","year":"2013","unstructured":"Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C, Staurenghi G (2013) Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer\u2019s disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54:5953\u20135958. https:\/\/doi.org\/10.1167\/iovs.13-12046","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1935_CR79","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev-vision-030320-041255","volume":"6","author":"DT Miller","year":"2020","unstructured":"Miller DT, Kurokawa K (2020) Cellular-Scale imaging of transparent retinal structures and processes using adaptive Optics Optical Coherence Tomography. Annu Rev Vis Sci 6:115\u2013148. https:\/\/doi.org\/10.1146\/annurev-vision-030320-041255","journal-title":"Annu Rev Vis Sci"},{"key":"1935_CR80","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"1935_CR81","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fnins.2020.00921","volume":"14","author":"N Mirzaei","year":"2020","unstructured":"Mirzaei N, Shi H, Oviatt M, Doustar J, Rentsendorj A, Fuchs DT, Sheyn J, Black KL, Koronyo Y, Koronyo-Hamaoui M (2020) Alzheimer\u2019s retinopathy: seeing Disease in the eyes. Front Neurosci 14:921. https:\/\/doi.org\/10.3389\/fnins.2020.00921","journal-title":"Front Neurosci"},{"key":"1935_CR82","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME (2021) Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research. Alzheimers Dement 17:1554\u20131574. https:\/\/doi.org\/10.1002\/alz.12321","journal-title":"Alzheimers Dement"},{"key":"1935_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"1935_CR84","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1021\/acschemneuro.9b00331","volume":"10","author":"SS More","year":"2019","unstructured":"More SS, Beach JM, McClelland C, Mokhtarzadeh A, Vince R (2019) In vivo Assessment of retinal biomarkers by Hyperspectral Imaging: early detection of Alzheimer\u2019s Disease. ACS Chem Neurosci 10:4492\u20134501. https:\/\/doi.org\/10.1021\/acschemneuro.9b00331","journal-title":"ACS Chem Neurosci"},{"key":"1935_CR85","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412\u20132414. https:\/\/doi.org\/10.1212\/wnl.43.11.2412-a","journal-title":"Neurology"},{"key":"1935_CR86","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","volume":"2","author":"L Mucke","year":"2012","unstructured":"Mucke L, Selkoe DJ (2012) Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med 2:a006338. https:\/\/doi.org\/10.1101\/cshperspect.a006338","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1935_CR87","doi-asserted-by":"publisher","first-page":"226","DOI":"10.24272\/j.issn.2095-8137.2022.308","volume":"44","author":"FM Nadal-Nicol\u00e1s","year":"2023","unstructured":"Nadal-Nicol\u00e1s FM, Galindo-Romero C, Lucas-Ruiz F, Marsh-Amstrong N, Li W, Vidal-Sanz M, Agudo-Barriuso M (2023) Pan-retinal ganglion cell markers in mice, rats, and rhesus macaques. Zool Res 44:226\u2013248. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2022.308","journal-title":"Zool Res"},{"key":"1935_CR88","doi-asserted-by":"publisher","unstructured":"Ngolab J, Donohue M, Belsha A, Salazar J, Cohen P, Jaiswal S, Tan V, Gessert D, Korouri S, Aggarwal NT et al (2021) Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer\u2019s Disease (A4) trial. Alzheimers Dement (Amst) 13:e12199. https:\/\/doi.org\/10.1002\/dad2.12199","DOI":"10.1002\/dad2.12199"},{"key":"1935_CR89","doi-asserted-by":"publisher","unstructured":"Nunez-Diaz C, Andersson E, Schultz N, Poceviciute D, Hansson O, Netherlands Brain B, Nilsson KPR, Wennstrom M (2024) The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer\u2019s disease patients and App(NL-F\/NL-F) mice. Alzheimers Res Ther 16(1):4. https:\/\/doi.org\/10.1186\/s13195-023-01375-7","DOI":"10.1186\/s13195-023-01375-7"},{"key":"1935_CR90","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/archneur.65.7.963","volume":"65","author":"SE O\u2019Bryant","year":"2008","unstructured":"O\u2019Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA (2008) Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol 65:963\u2013967. https:\/\/doi.org\/10.1001\/archneur.65.7.963","journal-title":"Arch Neurol"},{"key":"1935_CR91","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1167\/iovs.19-26683","volume":"60","author":"H Oku","year":"2019","unstructured":"Oku H, Kida T, Horie T, Taki K, Mimura M, Kojima S, Ikeda T (2019) Tau is involved in death of retinal ganglion cells of rats from Optic nerve crush. Invest Ophthalmol Vis Sci 60:2380\u20132387. https:\/\/doi.org\/10.1167\/iovs.19-26683","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1935_CR92","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis M, Vandenabeele P (2015) Necroptosis and its role in inflammation. Nature 517:311\u2013320. https:\/\/doi.org\/10.1038\/nature14191","journal-title":"Nature"},{"key":"1935_CR93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2014.08.032","volume":"73","author":"E Peeraer","year":"2015","unstructured":"Peeraer E, Bottelbergs A, Van Kolen K, Stancu IC, Vasconcelos B, Mahieu M, Duytschaever H, Ver Donck L, Torremans A, Sluydts E et al (2015) Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice. Neurobiol Dis 73:83\u201395. https:\/\/doi.org\/10.1016\/j.nbd.2014.08.032","journal-title":"Neurobiol Dis"},{"key":"1935_CR94","doi-asserted-by":"publisher","unstructured":"Pereiro X, Ruzafa N, Urcola JH, Sharma SC, Vecino E (2020) Differential distribution of RBPMS in Pig, Rat, and human retina after Damage. Int J Mol Sci 21(23):9330. https:\/\/doi.org\/10.3390\/ijms21239330","DOI":"10.3390\/ijms21239330"},{"key":"1935_CR95","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neulet.2006.06.049","volume":"405","author":"N Piri","year":"2006","unstructured":"Piri N, Kwong JM, Song M, Caprioli J (2006) Expression of hermes gene is restricted to the ganglion cells in the retina. Neurosci Lett 405:40\u201345. https:\/\/doi.org\/10.1016\/j.neulet.2006.06.049","journal-title":"Neurosci Lett"},{"key":"1935_CR96","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-020-2503-3","volume":"11","author":"N Puangmalai","year":"2020","unstructured":"Puangmalai N, Bhatt N, Montalbano M, Sengupta U, Gaikwad S, Ventura F, McAllen S, Ellsworth A, Garcia S, Kayed R (2020) Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer\u2019s disease, progressive supranuclear palsy and dementia with Lewy bodies. Cell Death Dis 11:314. https:\/\/doi.org\/10.1038\/s41419-020-2503-3","journal-title":"Cell Death Dis"},{"key":"1935_CR97","unstructured":"Purves DAGJ, Fitzpatrick D, Katz LC, LaMantia A-S, McNamara JO, William SM (2001) Neuroscience, 2nd edition. Sunderland (MA): Sinauer Associates, City"},{"key":"1935_CR98","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1167\/tvst.9.2.47","volume":"9","author":"Y Qiu","year":"2020","unstructured":"Qiu Y, Jin T, Mason E, Campbell MCW (2020) Predicting Thioflavin fluorescence of retinal amyloid deposits Associated with Alzheimer\u2019s Disease from their Polarimetric Properties. Transl Vis Sci Technol 9:47. https:\/\/doi.org\/10.1167\/tvst.9.2.47","journal-title":"Transl Vis Sci Technol"},{"key":"1935_CR99","doi-asserted-by":"publisher","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated Tau in Alzheimer\u2019s Disease and Other Tauopathies. Int J Mol Sci 23(21):12841. https:\/\/doi.org\/10.3390\/ijms232112841","DOI":"10.3390\/ijms232112841"},{"key":"1935_CR100","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JAD-181263","volume":"69","author":"M Regalado-Reyes","year":"2019","unstructured":"Regalado-Reyes M, Furcila D, Hernandez F, Avila J, DeFelipe J, Leon-Espinosa G (2019) Phospho-tau changes in the human CA1 during Alzheimer\u2019s Disease Progression. J Alzheimers Dis 69:277\u2013288. https:\/\/doi.org\/10.3233\/JAD-181263","journal-title":"J Alzheimers Dis"},{"key":"1935_CR101","doi-asserted-by":"publisher","first-page":"fcaa019","DOI":"10.1093\/braincomms\/fcaa019","volume":"2","author":"SL Risacher","year":"2020","unstructured":"Risacher SL, WuDunn D, Tallman EF, West JD, Gao S, Farlow MR, Brosch JR, Apostolova LG, Saykin AJ (2020) Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition. Brain Commun 2:fcaa019. https:\/\/doi.org\/10.1093\/braincomms\/fcaa019","journal-title":"Brain Commun"},{"key":"1935_CR102","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/cne.23521","volume":"522","author":"AR Rodriguez","year":"2014","unstructured":"Rodriguez AR, de Sevilla M\u00fcller LP, Brecha NC (2014) The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J Comp Neurol 522:1411\u20131443. https:\/\/doi.org\/10.1002\/cne.23521","journal-title":"J Comp Neurol"},{"key":"1935_CR103","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/WAD.0b013e3181b76415","volume":"24","author":"HC Rossetti","year":"2010","unstructured":"Rossetti HC, Munro Cullum C, Hynan LS, Lacritz LH (2010) The CERAD neuropsychologic battery total score and the progression of Alzheimer disease. Alzheimer Dis Assoc Disord 24:138\u2013142. https:\/\/doi.org\/10.1097\/WAD.0b013e3181b76415","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1935_CR104","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0002-9394(87)90001-8","volume":"104","author":"AA Sadun","year":"1987","unstructured":"Sadun AA, Borchert M, DeVita E, Hinton DR, Bassi CJ (1987) Assessment of visual impairment in patients with Alzheimer\u2019s disease. Am J Ophthalmol 104:113\u2013120. https:\/\/doi.org\/10.1016\/0002-9394(87)90001-8","journal-title":"Am J Ophthalmol"},{"key":"1935_CR105","doi-asserted-by":"publisher","first-page":"e0220535","DOI":"10.1371\/journal.pone.0220535","volume":"14","author":"E Salobrar-Garcia","year":"2019","unstructured":"Salobrar-Garcia E, de Hoz R, Ramirez AI, Lopez-Cuenca I, Rojas P, Vazirani R, Amarante C, Yubero R, Gil P, Pinazo-Duran MD et al (2019) Changes in visual function and retinal structure in the progression of Alzheimer\u2019s disease. PLoS ONE 14:e0220535. https:\/\/doi.org\/10.1371\/journal.pone.0220535","journal-title":"PLoS ONE"},{"key":"1935_CR106","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-neuro-071714-034120","volume":"38","author":"JR Sanes","year":"2015","unstructured":"Sanes JR, Masland RH (2015) The types of retinal ganglion cells: current status and implications for neuronal classification. Annu Rev Neurosci 38:221\u2013246. https:\/\/doi.org\/10.1146\/annurev-neuro-071714-034120","journal-title":"Annu Rev Neurosci"},{"key":"1935_CR107","doi-asserted-by":"publisher","first-page":"e53547","DOI":"10.1371\/journal.pone.0053547","volume":"7","author":"C Sch\u00f6n","year":"2012","unstructured":"Sch\u00f6n C, Hoffmann NA, Ochs SM, Burgold S, Filser S, Steinbach S, Seeliger MW, Arzberger T, Goedert M, Kretzschmar HA al (2012) Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS ONE 7:e53547. https:\/\/doi.org\/10.1371\/journal.pone.0053547","journal-title":"PLoS ONE"},{"key":"1935_CR108","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3233\/jad-190868","volume":"73","author":"N Schultz","year":"2020","unstructured":"Schultz N, Byman E, Wennstr\u00f6m M (2020) Levels of retinal Amyloid-\u03b2 correlate with levels of retinal IAPP and hippocampal Amyloid-\u03b2 in Neuropathologically evaluated individuals. J Alzheimers Dis 73:1201\u20131209. https:\/\/doi.org\/10.3233\/jad-190868","journal-title":"J Alzheimers Dis"},{"key":"1935_CR109","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1935_CR110","doi-asserted-by":"publisher","unstructured":"Shi H, Koronyo Y, Fuchs DT, Sheyn J, Jallow O, Mandalia K, Graham SL, Gupta VK, Mirzaei M, Kramerov AA et al (2023) Retinal arterial A\u03b240 deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients. Alzheimers Dement 19(11):5185\u20135197. https:\/\/doi.org\/10.1002\/alz.13086","DOI":"10.1002\/alz.13086"},{"key":"1935_CR111","doi-asserted-by":"publisher","unstructured":"Shi H, Koronyo Y, Rentsendorj A, Regis GC, Sheyn J, Fuchs DT, Kramerov AA, Ljubimov AV, Dumitrascu OM, Rodriguez AR (2020) Identification of early pericyte loss and vascular amyloidosis in Alzheimer\u2019s disease retina. Acta Neuropathol 139(5):813\u2013836. https:\/\/doi.org\/10.1007\/s00401-020-02134-w","DOI":"10.1007\/s00401-020-02134-w"},{"key":"1935_CR112","doi-asserted-by":"publisher","unstructured":"Shi H, Mirzaei N, Koronyo Y, Davis MR, Robinson E, Braun GM, Jallow O, Rentsendorj A, Ramanujan VK, Fert-Bober J et al (2024) Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status. Acta Neuropathol 148(1):3. https:\/\/doi.org\/10.1007\/s00401-024-02760-8","DOI":"10.1007\/s00401-024-02760-8"},{"key":"1935_CR113","doi-asserted-by":"publisher","unstructured":"Snyder PJ, Alber J, Alt C, Bain LJ, Bouma BE, Bouwman FH, DeBuc DC, Campbell MCW, Carrillo MC Chew EY (2021) Retinal imaging in Alzheimer\u2019s and neurodegenerative diseases. Alzheimers Dement 17: 103\u2013111 https:\/\/doi.org\/10.1002\/alz.12179","DOI":"10.1002\/alz.12179"},{"key":"1935_CR114","doi-asserted-by":"publisher","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr., Kaye J, Montine, TJ et al (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:280\u2013292. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"1935_CR115","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","volume":"77","author":"RA Sperling","year":"2020","unstructured":"Sperling RA, Donohue MC, Raman R, Sun CK, Yaari R, Holdridge K, Siemers E, Johnson KA, Aisen PS, Team AS (2020) Association of factors with elevated amyloid Burden in clinically normal older individuals. JAMA Neurol 77:735\u2013745. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0387","journal-title":"JAMA Neurol"},{"key":"1935_CR116","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/s0006-8993(01)02018-2","volume":"898","author":"JH Su","year":"2001","unstructured":"Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW (2001) Activated caspase-3 expression in Alzheimer\u2019s and aged control brain: correlation with Alzheimer pathology. Brain Res 898:350\u2013357. https:\/\/doi.org\/10.1016\/s0006-8993(01)02018-2","journal-title":"Brain Res"},{"key":"1935_CR117","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","volume":"80","author":"RN Taddei","year":"2023","unstructured":"Taddei RN, Perbet R, Mate de Gerando A, Wiedmer AE, Sanchez-Mico M, Connors Stewart T, Gaona A, Melloni A, Amaral AC, Duff K et al (2023) Tau oligomer-containing synapse elimination by microglia and astrocytes in Alzheimer disease. JAMA Neurol 80:1209\u20131221. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3530","journal-title":"JAMA Neurol"},{"key":"1935_CR118","doi-asserted-by":"publisher","unstructured":"Tadokoro K, Yamashita T, Kimura S, Nomura E, Ohta Y, Omote Y, Takemoto M, Hishikawa N, Morihara R, Morizane Y et al (2021) Retinal Amyloid Imaging for Screening Alzheimer\u2019s Disease. J Alzheimers Dis 83:927\u2013934 https:\/\/doi.org\/10.3233\/JAD-210327","DOI":"10.3233\/JAD-210327"},{"key":"1935_CR119","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","volume":"181","author":"HC Tai","year":"2012","unstructured":"Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT (2012) The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol 181:1426\u20131435. https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.033","journal-title":"Am J Pathol"},{"key":"1935_CR120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s0002-9394(14)75746-0","volume":"113","author":"WN Tenhula","year":"1992","unstructured":"Tenhula WN, Xu SZ, Madigan MC, Heller K, Freeman WR, Sadun AA (1992) Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol 113:14\u201320. https:\/\/doi.org\/10.1016\/s0002-9394(14)75746-0","journal-title":"Am J Ophthalmol"},{"key":"1935_CR121","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00401-024-02722-0","volume":"147","author":"DR Thal","year":"2024","unstructured":"Thal DR, Gawor K, Moonen S (2024) Regulated cell death and its role in Alzheimer\u2019s disease and amyotrophic lateral sclerosis. Acta Neuropathol 147:69. https:\/\/doi.org\/10.1007\/s00401-024-02722-0","journal-title":"Acta Neuropathol"},{"key":"1935_CR122","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791","journal-title":"Neurology"},{"key":"1935_CR123","doi-asserted-by":"publisher","unstructured":"Theofilas P, Ehrenberg AJ, Nguy A, Thackrey JM, Dunlop S, Mejia MB, Alho AT, Paraizo Leite RE, Rodriguez RD, Suemoto CK et al (2018) Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer\u2019s disease Braak stages: a quantitative study in humans. Neurobiol Aging 61:1\u201312 https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.09.007","DOI":"10.1016\/j.neurobiolaging.2017.09.007"},{"key":"1935_CR124","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1073\/pnas.1306759110","volume":"110","author":"ND Thomsen","year":"2013","unstructured":"Thomsen ND, Koerber JT, Wells JA (2013) Structural snapshots reveal distinct mechanisms of procaspase-3 and\u2013\u20097 activation. Proc Natl Acad Sci U S A 110:8477\u20138482. https:\/\/doi.org\/10.1073\/pnas.1306759110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1935_CR125","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ana.410260208","volume":"26","author":"GL Trick","year":"1989","unstructured":"Trick GL, Barris MC, Bickler-Bluth M (1989) Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann Neurol 26:226\u2013231. https:\/\/doi.org\/10.1002\/ana.410260208","journal-title":"Ann Neurol"},{"key":"1935_CR126","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00401-007-0200-2","volume":"113","author":"T Uchihara","year":"2007","unstructured":"Uchihara T (2007) Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 113:483\u2013499. https:\/\/doi.org\/10.1007\/s00401-007-0200-2","journal-title":"Acta Neuropathol"},{"key":"1935_CR127","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00401-023-02657-y","volume":"147","author":"BL van der Gaag","year":"2024","unstructured":"van der Gaag BL, Deshayes NAC, Breve JJP, Bol J, Jonker AJ, Hoozemans JJM, Courade JP, van de Berg WDJ (2024) Distinct tau and alpha-synuclein molecular signatures in Alzheimer\u2019s disease with and without Lewy bodies and Parkinson\u2019s disease with dementia. Acta Neuropathol 147:14. https:\/\/doi.org\/10.1007\/s00401-023-02657-y","journal-title":"Acta Neuropathol"},{"key":"1935_CR128","doi-asserted-by":"publisher","first-page":"17359","DOI":"10.1038\/s41598-020-71460-6","volume":"10","author":"KB VanderWall","year":"2020","unstructured":"VanderWall KB, Lu B, Alfaro JS, Allsop AR, Carr AS, Wang S, Meyer JS (2020) Differential susceptibility of retinal ganglion cell subtypes in acute and chronic models of injury and disease. Sci Rep 10:17359. https:\/\/doi.org\/10.1038\/s41598-020-71460-6","journal-title":"Sci Rep"},{"key":"1935_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13424","author":"G Walkiewicz","year":"2024","unstructured":"Walkiewicz G, Ronisz A, Van Ginderdeuren R, Lemmens S, Bouwman FH, Hoozemans JJM, Morrema THJ, Rozemuller AJ, Hart de Ruyter FJ, De Groef L et al (2024) Primary retinal tauopathy: a tauopathy with a distinct molecular pattern. Alzheimers Dement 20(1):330\u2013340. https:\/\/doi.org\/10.1002\/alz.13424","journal-title":"Alzheimers Dement: Doi"},{"key":"1935_CR130","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40478-020-00996-5","volume":"8","author":"VI Wiersma","year":"2020","unstructured":"Wiersma VI, Hoozemans JJM, Scheper W (2020) Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies. Acta Neuropathol Commun 8(1):153. https:\/\/doi.org\/10.1186\/s40478-020-00996-5","journal-title":"Acta Neuropathol Commun"},{"key":"1935_CR131","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","volume":"10","author":"QA Xu","year":"2022","unstructured":"Xu QA, Boerkoel P, Hirsch-Reinshagen V, Mackenzie IR, Hsiung GR, Charm G, To EF, Liu AQ, Schwab K, Jiang K et al (2022) Muller cell degeneration and microglial dysfunction in the Alzheimer\u2019s retina. Acta Neuropathol Commun 10:145. https:\/\/doi.org\/10.1186\/s40478-022-01448-y","journal-title":"Acta Neuropathol Commun"},{"key":"1935_CR132","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.psc.2022.07.003","volume":"45","author":"BC Yarns","year":"2022","unstructured":"Yarns BC, Holiday KA, Carlson DM, Cosgrove CK, Melrose RJ (2022) Pathophysiology of Alzheimer\u2019s Disease. Psychiatr Clin North Am 45:663\u2013676. https:\/\/doi.org\/10.1016\/j.psc.2022.07.003","journal-title":"Psychiatr Clin North Am"},{"key":"1935_CR133","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.3233\/JAD-220809","volume":"94","author":"R Zhang","year":"2023","unstructured":"Zhang R, Song Y, Su X (2023) Necroptosis and Alzheimer\u2019s Disease: pathogenic mechanisms and Therapeutic opportunities. J Alzheimers Dis 94:S367\u2013S386. https:\/\/doi.org\/10.3233\/JAD-220809","journal-title":"J Alzheimers Dis"},{"key":"1935_CR134","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid beta-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8:248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Signal Transduct Target Ther"},{"key":"1935_CR135","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1038\/s41467-024-50309-w","volume":"15","author":"B Zhao","year":"2024","unstructured":"Zhao B, Li Y, Fan Z, Wu Z, Shu J, Yang X, Yang Y, Wang X, Li B, Wang X et al (2024) Eye-brain connections revealed by multimodal retinal and brain imaging genetics. Nat Commun 15:6064. https:\/\/doi.org\/10.1038\/s41467-024-50309-w","journal-title":"Nat Commun"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-01935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-01935-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-01935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:12:33Z","timestamp":1739578353000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-01935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1935"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-01935-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.17.613293","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is not considered a human subjects research, and we confirm that consent was not necessary, for the reasons described as follow: we processed and analyzed deidentified retinal tissues of deceased patients that were provided by the USC-ADRC (IRB protocol HS-042071) and NDRI (Cedars-Sinai Medical Center IRB protocol Pro00019393). Histological studies at Cedars-Sinai Medical Center were performed under IRB protocols Pro00053412 and Pro00019393.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests specific to this research work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}